351 related articles for article (PubMed ID: 28827412)
1. Macrophage Liver Kinase B1 Inhibits Foam Cell Formation and Atherosclerosis.
Liu Z; Zhu H; Dai X; Wang C; Ding Y; Song P; Zou MH
Circ Res; 2017 Oct; 121(9):1047-1057. PubMed ID: 28827412
[TBL] [Abstract][Full Text] [Related]
2. Macrophage sortilin promotes LDL uptake, foam cell formation, and atherosclerosis.
Patel KM; Strong A; Tohyama J; Jin X; Morales CR; Billheimer J; Millar J; Kruth H; Rader DJ
Circ Res; 2015 Feb; 116(5):789-96. PubMed ID: 25593281
[TBL] [Abstract][Full Text] [Related]
3. Vav Guanine nucleotide exchange factors regulate atherosclerotic lesion development in mice.
Rahaman SO; Li W; Silverstein RL
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2053-7. PubMed ID: 23825362
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Orai1 Store-Operated Calcium Channel Prevents Foam Cell Formation and Atherosclerosis.
Liang SJ; Zeng DY; Mai XY; Shang JY; Wu QQ; Yuan JN; Yu BX; Zhou P; Zhang FR; Liu YY; Lv XF; Liu J; Ou JS; Qian JS; Zhou JG
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):618-28. PubMed ID: 26916730
[TBL] [Abstract][Full Text] [Related]
5. Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering.
Yu P; Xiong T; Tenedero CB; Lebeau P; Ni R; MacDonald ME; Gross PL; Austin RC; Trigatti BL
Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):26-39. PubMed ID: 29162602
[TBL] [Abstract][Full Text] [Related]
6. Stimulatory effects of cardiotrophin 1 on atherosclerosis.
Konii H; Sato K; Kikuchi S; Okiyama H; Watanabe R; Hasegawa A; Yamamoto K; Itoh F; Hirano T; Watanabe T
Hypertension; 2013 Nov; 62(5):942-50. PubMed ID: 24041953
[TBL] [Abstract][Full Text] [Related]
7. Enhanced foam cell formation, atherosclerotic lesion development, and inflammation by combined deletion of ABCA1 and SR-BI in Bone marrow-derived cells in LDL receptor knockout mice on western-type diet.
Zhao Y; Pennings M; Hildebrand RB; Ye D; Calpe-Berdiel L; Out R; Kjerrulf M; Hurt-Camejo E; Groen AK; Hoekstra M; Jessup W; Chimini G; Van Berkel TJ; Van Eck M
Circ Res; 2010 Dec; 107(12):e20-31. PubMed ID: 21071707
[TBL] [Abstract][Full Text] [Related]
8. Epac1 (Exchange Protein Directly Activated by cAMP 1) Upregulates LOX-1 (Oxidized Low-Density Lipoprotein Receptor 1) to Promote Foam Cell Formation and Atherosclerosis Development.
Robichaux WG; Mei FC; Yang W; Wang H; Sun H; Zhou Z; Milewicz DM; Teng BB; Cheng X
Arterioscler Thromb Vasc Biol; 2020 Dec; 40(12):e322-e335. PubMed ID: 33054390
[TBL] [Abstract][Full Text] [Related]
9. TREM2 promotes cholesterol uptake and foam cell formation in atherosclerosis.
Guo X; Li B; Wen C; Zhang F; Xiang X; Nie L; Chen J; Mao L
Cell Mol Life Sci; 2023 May; 80(5):137. PubMed ID: 37133566
[TBL] [Abstract][Full Text] [Related]
10. Impact of glutathione peroxidase-1 deficiency on macrophage foam cell formation and proliferation: implications for atherogenesis.
Cheng F; Torzewski M; Degreif A; Rossmann H; Canisius A; Lackner KJ
PLoS One; 2013; 8(8):e72063. PubMed ID: 23991041
[TBL] [Abstract][Full Text] [Related]
11. NG2 Proteoglycan Ablation Reduces Foam Cell Formation and Atherogenesis via Decreased Low-Density Lipoprotein Retention by Synthetic Smooth Muscle Cells.
She ZG; Chang Y; Pang HB; Han W; Chen HZ; Smith JW; Stallcup WB
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):49-59. PubMed ID: 26543095
[TBL] [Abstract][Full Text] [Related]
12. The P2RY12 receptor promotes VSMC-derived foam cell formation by inhibiting autophagy in advanced atherosclerosis.
Pi S; Mao L; Chen J; Shi H; Liu Y; Guo X; Li Y; Zhou L; He H; Yu C; Liu J; Dang Y; Xia Y; He Q; Jin H; Li Y; Hu Y; Miao Y; Yue Z; Hu B
Autophagy; 2021 Apr; 17(4):980-1000. PubMed ID: 32160082
[TBL] [Abstract][Full Text] [Related]
13. IL-33 reduces macrophage foam cell formation.
McLaren JE; Michael DR; Salter RC; Ashlin TG; Calder CJ; Miller AM; Liew FY; Ramji DP
J Immunol; 2010 Jul; 185(2):1222-9. PubMed ID: 20543107
[TBL] [Abstract][Full Text] [Related]
14. Nucleolin protects macrophages from oxLDL-induced foam cell formation through up-regulating ABCA1 expression.
Li Y; Jiang B; Liang P; Tong Z; Liu M; Lv Q; Liu Y; Liu X; Tang Y; Xiao X
Biochem Biophys Res Commun; 2017 Apr; 486(2):364-371. PubMed ID: 28315324
[TBL] [Abstract][Full Text] [Related]
15. Adipocyte enhancer-binding protein 1 (AEBP1) (a novel macrophage proinflammatory mediator) overexpression promotes and ablation attenuates atherosclerosis in ApoE (-/-) and LDLR (-/-) mice.
Bogachev O; Majdalawieh A; Pan X; Zhang L; Ro HS
Mol Med; 2011; 17(9-10):1056-64. PubMed ID: 21687917
[TBL] [Abstract][Full Text] [Related]
16. Grb2 is required for atherosclerotic lesion formation.
Proctor BM; Ren J; Chen Z; Schneider JG; Coleman T; Lupu TS; Semenkovich CF; Muslin AJ
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1361-7. PubMed ID: 17363695
[TBL] [Abstract][Full Text] [Related]
17. Naoxintong Retards Atherosclerosis by Inhibiting Foam Cell Formation Through Activating Pparα Pathway.
Wang Z; Shi H; Zhao H; Dong Z; Zhao B; Weng X; Liu R; Li X; Hu K; Zou Y; Sun A; Ge J
Curr Mol Med; 2018; 18(10):698-710. PubMed ID: 30734676
[TBL] [Abstract][Full Text] [Related]
18. Receptor-independent fluid-phase macropinocytosis promotes arterial foam cell formation and atherosclerosis.
Lin HP; Singla B; Ahn W; Ghoshal P; Blahove M; Cherian-Shaw M; Chen A; Haller A; Hui DY; Dong K; Zhou J; White J; Stranahan AM; Jasztal A; Lucas R; Stansfield BK; Fulton D; Chlopicki S; Csányi G
Sci Transl Med; 2022 Sep; 14(663):eadd2376. PubMed ID: 36130017
[TBL] [Abstract][Full Text] [Related]
19. Enzymatically Modified Low-Density Lipoprotein Promotes Foam Cell Formation in Smooth Muscle Cells via Macropinocytosis and Enhances Receptor-Mediated Uptake of Oxidized Low-Density Lipoprotein.
Chellan B; Reardon CA; Getz GS; Hofmann Bowman MA
Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1101-13. PubMed ID: 27079883
[TBL] [Abstract][Full Text] [Related]
20. Postprandial lipoproteins and the molecular regulation of vascular homeostasis.
Botham KM; Wheeler-Jones CP
Prog Lipid Res; 2013 Oct; 52(4):446-64. PubMed ID: 23774609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
